mRNA vaccines
Approval
- What happened
The FDA authorized the Pfizer-BioNTech vaccine for emergency use in people 16 and older, based on a randomized, blinded trial in thousands of people.
- How far from your life
Everyday life
mRNA vaccines in lipid nanoparticles is on step 5 of 5. It is probably already in your life.
- Source
“The first EUA, issued Dec. 11, for the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older”US FDA, 23 Aug 2021
The bigger picture
More on mRNA vaccines
On step 5 of 5: Everyday life. Everything we track on it
- Approval
The FDA fully approved the Pfizer-BioNTech vaccine, now sold as Comirnaty: the first COVID-19 vaccine to get full approval. Its review covered about 20,000 people who got the vaccine and 20,000 who got a placebo.
US FDA, 23 Aug 2021 - Widely usedCompany-reported
Pfizer and BioNTech had supplied more than one billion doses of their COVID-19 vaccine, BioNTech said.
Reuters, 9 Aug 2021